ArticleStructural heart : the journal of the Heart Team2025
Predicting Treatment of Bioprosthetic Aortic Valve Failure in the United States: A Proposed Model.
Article in Structural heart : the journal of the Heart Team, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Validation of an Automated Artificial Intelligence-Driven Planner for Transcatheter Aortic Valve Replacement.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Article
- Mortality and morbidity benefits of surgical versus transcatheter aortic valve replacement in patients ≤60 years: Findings from a national cohort.JTCVS open · 2026Article
- Multicenter Experience of Aortic Valve Leaflet Modification in TAVR: From the Asia-Pacific Electrosurgery Working Group.JACC. Asia · 2026Article
- Geometric coronary constraints and anatomical feasibility of redo TAVR in Asian patients with Evolut valves: A CT-based simulation study.Cardiovascular intervention and therapeutics · 2026Article
- Managing Transcatheter Aortic Valve Failure.Structural heart : the journal of the Heart Team · 2026Review
- Closed-loop Control of Steerable Balloon Endoscopes for Robot-assisted Transcatheter Intracardiac Procedures.IEEE robotics and automation letters · 2026Article
- Redo-Transcatheter Aortic Valve Implantation (Redo-TAVI)-Pilot Study from Multicentre Nationwide Registry.Journal of clinical medicine · 2025Article
- Predicting the Surge in Valve-in-Valve Volume: A Comparative Study of Japan and the United States.JACC. Asia · 2025Article
- Four-Step Framework for Valve-in-Valve Transcatheter Aortic Valve Replacement for Failed Surgical and Transcatheter Aortic Bioprostheses.Reviews in cardiovascular medicine · 2025Review
- A comparison of laser, electrosurgical, and mechanical transcatheter traversal of calcified aortic valve leaflets.JTCVS structural and endovascular · 2025Article
- Transfemoral Transseptal Mitral Valve-in-Valve-in-Valve of a Degenerated Transcatheter in Surgical Bioprosthesis.JACC. Case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
•Transcatheter aortic valve replacement (TAVR) is the dominant treatment for aortic stenosis; the need to treat TAVR failure is increasing.•TAVR valve-in-valve (ViV) is predicted to reach ∼42,000 procedures by 2035.•TAVR ViV will represent ∼15% of all TAVR performed by 2035.•TAVR-in-TAVR will match TAVR-in-surgical aortic valve replacement by 2028 and dominate thereafter.•To ensure the viability of TAVR ViV, the use of leaflet modification is needed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.